The Europe Autoinjectors Market would witness market growth of 17.1% CAGR during the forecast period (2020-2026). Auto-injectors have numerous advantages like they lessen phobia and anxiety related to needles, decrease chances of a needle stuck incidences, keep the consistency of dose precision, and also help with better efficiency, which, in turn, support growth. Drug delivery by using an auto-injector is more controlled than manual injection.
The administration site of any drug is chosen on the basis of the nature of the drug; however, it is usually administered intramuscularly. Autoinjectors, if compared to syringes, are less painful, thus demand is increasing. Though, the availability of substitutes like oral tablets may obstruct growth.
In a reasonably short time period, the market for self-injection devices has full-fledged into a conspicuous and promising segment in the pharmaceutical industry. Autoinjectors are one such device that has witnessed amplified adoption among patients, particularly for the treatment of emergency situations like anaphylactic shocks. As per the developers, these devices are quite easier to use as compared to parenteral drug delivery systems and have incorporated needle-safety features. It has been proved that the autoinjectors have resolved a number of issues faced by patients such as injection-related tolerability.
Based on Type, the market is segmented into Disposable autoinjectors and Reusable autoinjectors. Based on Application, the market is segmented into Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications. Based on End Use, the market is segmented into Hospitals & Clinics and Home care settings. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: Autoinjectors Market in Europe is expected to register a CAGR of 17.1% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Disposable autoinjectors
- Reusable autoinjectors
By Application
- Anaphylaxis
- Rheumatoid Arthritis
- Multiple Sclerosis
- Other Applications
By End Use
- Hospitals & Clinics
- Home care settings
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Eli Lilly and Company
- GlaxoSmithKline PLC (GSK)
- Merck Group
- Sanofi S.A.
- Becton, Dickinson and Company
- Teva Pharmaceuticals Industries Ltd.
- Amgen, Inc.
- Ypsomed AG
- AbbVie, Inc.
- Biogen, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Autoinjectors Market, by Type
1.4.2 Europe Autoinjectors Market, by Application
1.4.3 Europe Autoinjectors Market, by End Use
1.4.4 Europe Autoinjectors Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May – 2020, Nov) Leading Players
Chapter 4. Europe Autoinjectors Market by Type
4.1 Europe Disposable autoinjectors Market by Country
4.2 Europe Reusable autoinjectors Market by Country
Chapter 5. Europe Autoinjectors Market by Application
5.1 Europe Anaphylaxis Market by Country
5.2 Europe Rheumatoid Arthritis Market by Country
5.3 Europe Multiple Sclerosis Market by Country
5.4 Europe Other Application Market by Country
Chapter 6. Europe Autoinjectors Market by End Use
6.1 Europe Hospitals & Clinics Autoinjectors Market by Country
6.2 Europe Home care settings Autoinjectors Market by Country
Chapter 7. Europe Autoinjectors Market by Country
7.1 Germany Autoinjectors Market
7.1.1 Germany Autoinjectors Market by Type
7.1.2 Germany Autoinjectors Market by Application
7.1.3 Germany Autoinjectors Market by End Use
7.2 UK Autoinjectors Market
7.2.1 UK Autoinjectors Market by Type
7.2.2 UK Autoinjectors Market by Application
7.2.3 UK Autoinjectors Market by End Use
7.3 France Autoinjectors Market
7.3.1 France Autoinjectors Market by Type
7.3.2 France Autoinjectors Market by Application
7.3.3 France Autoinjectors Market by End Use
7.4 Russia Autoinjectors Market
7.4.1 Russia Autoinjectors Market by Type
7.4.2 Russia Autoinjectors Market by Application
7.4.3 Russia Autoinjectors Market by End Use
7.5 Spain Autoinjectors Market
7.5.1 Spain Autoinjectors Market by Type
7.5.2 Spain Autoinjectors Market by Application
7.5.3 Spain Autoinjectors Market by End Use
7.6 Italy Autoinjectors Market
7.6.1 Italy Autoinjectors Market by Type
7.6.2 Italy Autoinjectors Market by Application
7.6.3 Italy Autoinjectors Market by End Use
7.7 Rest of Europe Autoinjectors Market
7.7.1 Rest of Europe Autoinjectors Market by Type
7.7.2 Rest of Europe Autoinjectors Market by Application
7.7.3 Rest of Europe Autoinjectors Market by End Use
Chapter 8. Company Profiles
8.1 Eli Lilly and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Geographical Expansions:
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.1 Recent strategies and developments:
8.2.1.1 Approvals:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Sanofi S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Approvals:
8.4.5.3 Product Launches and Product Expansions:
8.5 Becton, Dickinson and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Approvals:
8.7 Amgen, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Research & Development Expense
8.7.4 Recent strategies and developments:
8.7.4.1 Product Launches and Product Expansions:
8.8 Ypsomed AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 AbbVie, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. Biogen, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Europe Autoinjectors Market, 2016 - 2019, USD Million
TABLE 2 Europe Autoinjectors Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Auto-Injectors Market
TABLE 4 Product Launches And Product Expansions– Auto-Injectors Market
TABLE 5 Geographical Expansions– Auto-Injectors Market
TABLE 6 Approvals– Auto-Injectors Market
TABLE 7 Europe Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 8 Europe Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 9 Europe Disposable autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 10 Europe Disposable autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 11 Europe Reusable autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 12 Europe Reusable autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 13 Europe Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 14 Europe Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 15 Europe Anaphylaxis Market by Country, 2016 - 2019, USD Million
TABLE 16 Europe Anaphylaxis Market by Country, 2020 - 2026, USD Million
TABLE 17 Europe Rheumatoid Arthritis Market by Country, 2016 - 2019, USD Million
TABLE 18 Europe Rheumatoid Arthritis Market by Country, 2020 - 2026, USD Million
TABLE 19 Europe Multiple Sclerosis Market by Country, 2016 - 2019, USD Million
TABLE 20 Europe Multiple Sclerosis Market by Country, 2020 - 2026, USD Million
TABLE 21 Europe Other Application Market by Country, 2016 - 2019, USD Million
TABLE 22 Europe Other Application Market by Country, 2020 - 2026, USD Million
TABLE 23 Europe Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 24 Europe Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 25 Europe Hospitals & Clinics Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 26 Europe Hospitals & Clinics Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 27 Europe Home care settings Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 28 Europe Home care settings Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 29 Europe Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 30 Europe Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 31 Germany Autoinjectors Market, 2016 - 2019, USD Million
TABLE 32 Germany Autoinjectors Market, 2020 - 2026, USD Million
TABLE 33 Germany Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 34 Germany Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 35 Germany Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 36 Germany Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 37 Germany Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 38 Germany Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 39 UK Autoinjectors Market, 2016 - 2019, USD Million
TABLE 40 UK Autoinjectors Market, 2020 - 2026, USD Million
TABLE 41 UK Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 42 UK Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 43 UK Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 44 UK Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 45 UK Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 46 UK Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 47 France Autoinjectors Market, 2016 - 2019, USD Million
TABLE 48 France Autoinjectors Market, 2020 - 2026, USD Million
TABLE 49 France Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 50 France Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 51 France Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 52 France Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 53 France Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 54 France Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 55 Russia Autoinjectors Market, 2016 - 2019, USD Million
TABLE 56 Russia Autoinjectors Market, 2020 - 2026, USD Million
TABLE 57 Russia Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 58 Russia Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 59 Russia Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 60 Russia Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 61 Russia Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 62 Russia Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 63 Spain Autoinjectors Market, 2016 - 2019, USD Million
TABLE 64 Spain Autoinjectors Market, 2020 - 2026, USD Million
TABLE 65 Spain Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 66 Spain Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 67 Spain Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 68 Spain Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 69 Spain Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 70 Spain Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 71 Italy Autoinjectors Market, 2016 - 2019, USD Million
TABLE 72 Italy Autoinjectors Market, 2020 - 2026, USD Million
TABLE 73 Italy Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 74 Italy Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 75 Italy Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 76 Italy Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 77 Italy Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 78 Italy Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 79 Rest of Europe Autoinjectors Market, 2016 - 2019, USD Million
TABLE 80 Rest of Europe Autoinjectors Market, 2020 - 2026, USD Million
TABLE 81 Rest of Europe Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 82 Rest of Europe Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 83 Rest of Europe Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 84 Rest of Europe Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 85 Rest of Europe Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 86 Rest of Europe Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 87 Key Information – Eli Lilly and Company
TABLE 88 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 89 key Information – Merck Group
TABLE 90 Key Information – Sanofi S.A.
TABLE 91 Key information – Becton, Dickinson and Company
TABLE 92 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 93 Key Information – Amgen, Inc.
TABLE 94 Key Information –-Ypsomed AG
TABLE 95 Key information – AbbVie, Inc.
TABLE 96 Key Information – Biogen, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May – 2020, Nov) Leading Players
FIG 5 Recent strategies and developments: Eli Lilly and Company
FIG 6 Recent strategies and developments: Sanofi S.A.
FIG 7 Recent strategies and developments: Becton, Dickinson and Company
FIG 8 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.